Optical resolution of chlorohydrin with microorganism

Abstract: A novel method for preparing an optically active chlorohydrin compound and an optically active 1,2-diol compound and/or optically active 3-hydroxy-γ-butyrolactone which are useful as intermediates for preparing medicaments, agricultural chemicals, physiologically active substances and ferroelectric liquid crystals, which comprises treating a racemic chlorohydrin compound having the formula: [wherein R 1 is H or lower alkyl group; and R 2 is a substituted or unsubstituted lower alkyl group when R 1 is H; or R 2 is H when R 1 is a lower alkyl group] with a microorganism, thereby selectively degrading only one of optical isomers thereof, and recovering the remaining other optically active chlorohydrin and isolating optically active 1,2-diol compound and/or optically active 3-hydroxy-γ-butyrolactone converted by the reaction.

Description: This invention relates to an optical resolution of a chlorohydrin compound with a microorganism. More particularly, it relates to a process for the production of an optically active chlorohydrin compound from the corresponding racemic compound by a biological optical resolution using a microorganism, said optically active chlorohydrin compound being useful as an chiral building block and an intermediate for the production of optically active compounds having various utilities, such as medicaments, agricultural chemicals, physiologically active substances and ferroelectric liquid crystals. This invention provides also a process for the production of an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone in addition to the optically active chlorohydrin compound by the biological optical resolution of a racemic chlorohydrin compound, wherein the production of said other compounds depends on the kinds of the microorganism used as well as the kinds of the substituent of the starting chlorohydrin compound. Optically active compounds have usually been produced by a chemical synthesis comprising converting the corresponding optically active starting compound into the desired compound, or by an optical resolution comprising treating the corresponding racemic compound with an optically resolving agent, but recently, it is reported to produce the optically active compound by a biological optical resolution utilizing an asymmetric reduction or asymmetric hydrolysis of a racemic compound with a microorganism or an enzyme. For example, there is reported a process of an asymmetric reduction of a β-keto ester with a microbial cell or an enzyme, specifically an asymmetric reduction of a 4-chloroacetoacetate with a baker's yeast to give an optically active 4-chloro-3-hydroxybutyrate (cf. C.J. Sih et al., Ann. N.Y. Acad. Sci., Vol. 434, pp. 186-193, 1984; C.J. Sih, BE 898386). Santaniello et al. have reported a process for the production of ethyl 4-chloro-3-hydroxybutyrate by an asymmetric reduction of ethyl 4-chloro-3-oxobutyrate with a baker's yeast (cf. E. Santaniello et al., J. Chem. Research (S), pp. 132-133, 1984). Takahashi et al. have also reported a process for the production of an optically active ethyl 4-chloro-3-hydroxybutyrate by an asymmetric reduction of ethyl 4-chloro-3-oxobutyrate with a microorganism (cf. JP-A-61-146191). As a process using an enzyme, J. Peters et al. have reported a process for the production of (S)-methyl 3-hydroxybutyrate and (R)-ethyl 4-chloro-3-hydroxybutyrate by an asymmetric reduction of methyl 3-oxobutyrate or ethyl 4-chloro-3-oxobutyrate using a carbonyl reductase produced by Rhodococcus erythropolis (cf. J. Peters et al., Appl. Microbiol. Biotechnol., Vol. 38, pp. 334-340, 1992; T. Zelinski et al., J. Biotechnol., Vol. 33, pp. 283-292, 1994). Besides, Shimizu et al. have reported a process for the production of (R)-ethyl 4-chloro-3-hydroxybutyrate by an asymmetric reduction using an aldehyde reductase produced by Sporoboromyces salmonicolor AKU 4429 (cf. S. Shimizu et al., Biotechnol. Lett. Vol. 12, No. 8, pp. 593-596, 1990; Appl. Environ. Microbiol., Vol. 56, No. 8, pp. 2374-2377, 1990). However, according to these processes for the production of an optically active β-hydroxy ester compound from a prochiral β-keto ester compound by an asymmetric reduction using a microorganism or an enzyme, it is required to use very expensive coenzymes such as NADH (nicotinamide adenine dinucleotide) or NADPH (nicotinamide adenine dinucleotide phosphate), and it is further required to use additionally an enzyme such as glucose oxidase or formic acid dehydrogenase because of the necessity of a converting reaction from the oxidized form to the reduced form. Moreover, the rate of reaction is determined based on said converting reaction from the oxidized form to the reduced form. Thus, these known processes are not necessarily satisfactory from the industrial viewpoint. Nakamura et al. have reported a process for the production of (R)-4-chloro-3-hydroxybutyronitrile by using 1,3-dichloro-2-propanol or epichlorohydrin as a substrate, and treating the substrate with a dehydrogenase produced by Corynebacterium sp. N-1074 in the presence of KCN (cf. JP-A-3-53889, JP-A-3-53890). It is also reported to obtain an optically active 4-chloro-3-hydroxybutyronitrile or the corresponding ester by treating a recemic 4-chloro-3-hydroxybutyronitrile with a lipase in the presence of a fatty acid ester (cf. JP-A-2-27995). However, the optically active products obtained by these processes have low optical purity, and hence, are not suitable as an industrial process. Further, Lee et al. have reported a process for the production of (R)-1,2-propanediol compound and (R)-1,2-butanediol compound by the reduction of 1-hydroxy-2-propanone and 1-hydroxy-2-butanone with a glycerol dehydrogenase, respectively [cf. L.G. Lee, G.M. Whitesides, J. Org. Chem., Vol. 51, pp. 25-36 (1986)]. There is also known a process for the conversion of a 1-hydroxy-2-ketone compound into a (S)-1,2-diol compound by using cells of a microorganism (cf. JP-A-1-320988). However, these processes are a process for the production of a 1,2-diol compound by utilizing an asymmetric reduction with an enzyme or a microorganism, which is clearly distinguished from the process of the present invention which comprises treating a racemic chlorohydrin compound with cells of a microorganism and thereby converting only one optically active chlorohydrin in a racemic mixture into a 1,2-diol compound. Besides, for the purpose of producing an optically active 3-hydroxy-γ-butyrolactone which is useful as an intermediate for the production of an optically active compound to be used as a medicament, there are known various chemical processes and also some biological processes, for example, a process for the production of an optically active 3-hydroxy-γ-butyrolactone or the corresponding ester by transesterification of a 3-hydroxy-γ-butyrolactone with a lipase (cf. EP 0439779); a process for the production of (R)-3-hydroxy-γ-butyrolactone by asymmetrically reducing ethyl 4-t-butoxy-3-oxobutyrate with a baker's yeast, and converting the resulting (R)-4-t-butoxy-3-hydroxybutyrate into the desired compound in the presence of fluoroacetic acid (cf. Synthesis (1), pp. 37-40, 1986). However, these processes have some problems to be solved, that is, they require complicated procedures or use of very expensive agents and further require very expensive or hardly available starting materials. Besides, they are limited to the production of only one optically active compound among two isomers. Accordingly, these processes are not satisfactory for producing an optically active 3-hydroxy-γ-butyrolactone with ease and low cost. The present inventors had previously found a process for the production of an optically active compound from the corresponding racemic compound by using a microorganism which can hydrolyze and metabolize one of the optical isomers and hence can grow by utilizing the isomer as a single carbon source, for example, a process for the production of S-(+)-3-halogeno-1,2-propanediol using a bacteria of the genus Alcaligenes (cf. JP-A-3-191795, and J. of Fermentation & Bioengineering, Vol. 73, No. 6, pp. 443-448, 1992); a process for the production of R-(-)-3-halogeno-1,2-propandiol using a bacteria of the genus Pseudomonas (cf. JP-A-3-191794, and Applied Microbiology and Biotechnology, Vol. 40, pp. 273-278, 1993); a process for the production of an optically active dichloropropanol (R isomer) by using a bacteria of the genus Alcaligenes (cf. JP-A-3-180197, and J. of Industrial Microbiology, Vol. 10, pp. 37-43, 1992); a process for the production of an optically active dichloropropanol (S isomer) by using a bacteria of the genus Pseudomonas (cf. JP-A-61-132196, and Agric. Biol. Chem., Vol. 54, No. 12, pp. 3185-3190, 1990); and a process for the production of an optically active epichlorohydrin by treating an optically active dichloropropanol with an alkali, wherein said optically active dichloropropanol is obtained by using a bacteria of the genus Pseudomonas (cf. JP-A-1-55879, and Bulletin. of Association of Synthetic Organic Chemistry, Vol. 51, No. 5, pp. 388-398, 1993). The present inventors have intensively studied to find an improved process for the production of an optically active chlorohydrin compound from a racemic chlorohydrin on an industrial scale, and have found that certain microorganisms, particularly bacteria of the genuses Pseudomonas, Enterobacter, Citrobacter and Bacillus can degrade only one of the optical isomers of a racemic mixture of chlorohydrin compound, or convert one of the isomers into an optically active 1,2-diol compound owing to a degrading activity thereof, and optionally can further convert it into an optically active 3-hydroxy-y-butyrolactone, and hence, there can be obtained an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone as well as an optically active chlorohydrin compound. According to the investigation of the present inventors, it has been found that since these microorganisms can not assimilate one of the starting racemic mixture, contrary to the above-mentioned processes for the production of optically active halogenopropanediol or dichloropropanol, hence, it can not be used for the production of the optical isomer simultaneously with growing the microorganism in the medium. However, when the cells of the microorganism grown separately are applied to a racemic chlorohydrin compound, only one of the isomers is degraded, and the other one of the isomers remains in the reaction system, from which the desired optically active chlorohydrin compound can be recovered. It has also been found that, depending on the kinds of the microorganisms and/or on the kinds of the starting compounds, only one of the optical isomers can be converted into the corresponding 1,2-diol compound and/or 3-hydroxy-γ-butyrolactone, and hence, there can be obtained an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone in addition to the optically active chlorohydrin compound. Thus, an object of the invention is to provide a process for the production of an optically active chlorohydrin compound which comprises stereoselectively degrading one of the optical isomers in a cheap racemic mixture of the chlorohydrin compound with a microorganism and recovering the remaining optically active chlorohydrin from the reaction mixture. Another object of the invention is to provide a process for the production of an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone in addition to the optically active chlorohydrin compound, which comprises treating a racemic mixture of the chlorohydrin compound with a microorganism and thereby dechlorinating it to convert it into an optically active 1,2-diol compound, and further to convert it into an optically active 3-hydroxy-γ-butyrolactone, and then recovering these optically active compounds together with the remaining optically active chlorohydrin compound. These and other objects and advantages of the present invention will be apparent to those skilled in the art from the following descprition. This invention provides a process for the production of an optically active chlorohydrin compound, which comprises treating a racemic mixture of a chlorohydrin compound of the formula: wherein R 1 is a hydrogen atom or a lower alkyl group; and R 2 is a substituted or unsubstituted lower alkyl group when R 1 is a hydrogen atom, provided that a hydroxymethyl group (-CH 2 OH) is excluded, or R 2 is a hydrogen atom when R 1 is a lower alkyl group, with a microorganism, and thereby degrading selectively only one of the optical isomers in the racemic mixture, and then, recovering the another optically active isomer remaining in the reaction system. In the above process, depending on the kinds of the starting compounds and of the microorganisms, one of the optical isomers is converted to give an optically active 1,2-diol compound of the formula: wherein R 3 is a substituted or unsubstituted lower alkyl group, and also an optically active 3-hydroxy-γ-butyrolactone of the formula: and hence, there are obtained an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone in addition to the optically active chlorohydrin compound. In the present description, the term "lower alkyl group" for R 1 denotes an alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, butyl. The term "lower alkyl group" in the "substituted or unsubstituted lower alkyl" for R 2 and R 3 denotes an alkyl group having 1 to 3 carbon atoms, such as methyl, ethyl, propyl, and the substituents for the alkyl group includes a cyano group, a lower alkoxycarbonyl group of the formula: -COOR' (R' is a straight chain or branched chain alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl), or a lower alkoxy group of the formula: -OR" (R" is a straight chain or branched chain alkyl group having 1 to 4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl). Preferred examples of the substituted lower alkyl group are a cyanomethyl, a lower alkoxycarbonylmethyl, and a lower alkoxymethyl. The microorganisms used in this invention include any microorganism which can selectively degrade one of the optical isomers of the racemic chlorohydrin compound of the formula [1], preferably bacteria of the genuses Pseudomonas, Enterobacter, Citrobacter and Bacillus. Among them, particularly preferred ones are Pseudomonas sp. OS-K-29, Pseudomonas sp. DS-K-NR 818, Enterobacter sp. DS-S-75, Citrobacter freundii DS-S-13, Citrobacter freundii DS-K-40, and Bacillus sphaericus DS-ID-819. These microorganisms have no ability of assimilating the chlorohydrin compound [1], and hence, the cells obtained by growing them are used for the stereoselective degradation of the racemic chlorohydrin compound. An embodiment of the starting racemic chlorohydrin derivatives represented by the formula [1] is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is a substituted or unsubstituted alkyl group in which the alkyl moiety has 1 to 3 carbon atoms. An embodiment of the starting racemic chlorohydrin derivatives represented by the formula [1] is a compound of the formula [1] wherein R 2 is a member selected from the group consisting of an ethyl group, a cyanomethyl group, an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and an alkoxymethyl group in which the alkyl moiety has 1 to 4 carbon atoms. An embodiment of the starting racemic chlorohydrin derivatives represented by the formula [1] is a compound of the formula [1], wherein R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms. An embodiment of the starting racemic chlorohydrin derivatives represented by the formula [1] is a compound of the formula [1], wherein R 2 is a member selected from the group consisting of methoxycarbonylmethyl, ethoxycarbonylmethyl, and isopropoxycarbonylmethyl. An embodiment of the starting racemic chlorohydrin derivatives represented by the formula [1] is a compound of the formula [1] is a compound of the formula [1] wherein R 1 is an alkyl group having 1 to 4 carbon atoms and R 2 is a hydrogen atom. The present invention includes a process for the optical resolution of a racemic chlorohydrin compound, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and the microorganism is Pseudomonas sp. OS-K-29 (Deposit number of FERM BP-994), and thereby an optically active 1,2-diol compound of the formula: wherein R 3' is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and further an optically active 3-hydroxy-butyrolactone of the above formula are produced in addition to the optically active chlorohydrin compound. The above process of the present invention also includes the following embodiment: The above process, wherein R 3' is a member selected from the group consisting of methoxycarbonylmethyl, ethoxycarbonylmethyl, and isopropoxycarbonylmethyl. The above process, wherein the microorganism is Pseudomonas sp. DS-K-NR 818 (Deposit number of FERM BP-5491). The above process, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and the microorganism is a member selected from the group consisting of Pseudomonas sp. DS-K-NR 818 (Deposit number of FERM BP-5491), Enterobacter sp. DS-S-75 (Deposit number of FERM BP-5494), Citrobacter freundii DS-S-13 (Deposit number of FERM BP-5492), Citrobacter freundii DS-K-40 (Deposit number of FERM BP-5493), and Bacillus sphaericus DS-ID-819 (Deposit number of FERM BP-5495), and thereby an optically active 3-hydroxy--butyrolactone of the above formula is produced in addition to the optically active chlorohydrin compound. The above process, wherein the R 2 in the starting compound [1] is a member selected from the group consisting of methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, isopropoxycarbonylmethyl, and butyloxycarbonylmethyl. A preferred embodiment of the present invention is a process as shown in the following Reaction Scheme-1 (provided that only when the R 3 in the formula [1a] is a lower alkoxycarbonylmethyl, the 3-hydroxy-γ-butyrolactone [3a] is produced): wherein R 3 is the same as defined above. In the process as shown in the above Reaction Scheme-1, a more preferred embodiment is a process using a compound of the formula [1a] wherein R 3 is a cyanomethyl or a lower alkoxycarbonylmethyl. In the process of the above Reaction Scheme-1 wherein R 3 is a lower alkoxycarbonylmethyl, there are produced an optically active 3-hydroxy-γ-butyrolactone [3a] in addition to the optically active 1,2-diol compound [2a], and these optically active 1,2-diol compound [2a] and optically active 3-hydroxy-γ-butyrolactone [3a] are usually in the form of R-isomer as shown by the following formula, respectively. wherein R 3' is a lower alkoxycarbonylmethyl group. Another preferred embodiment of the present invention is a process as shown by the following Reaction Scheme-2: wherein R 3' is the same as defined above. In the process of the above Reaction Scheme-2, other bacteria of the genus Enterobacter, Citrobacter and Bacillus as mentioned hereinbefore are also preferably used. The optically active 3-hydroxy-y-butyrolactone [3b] obtained by this process is usually in the form of an S-isomer as shown by the following formula, while in case of using Bacillus sphaericus DS-ID-819 and using the starting compound [1b] wherein R 3' is other than n-butyloxy carbonylmethyl group, the product is in the form of an R-isomer. A further preferred embodiment of the present invention is a process as shown by the following Reaction Scheme-3: wherein R 1' is a lower alkyl group. The specific microorganism, Pseudomonas sp. OS-K-29 used in the present invention has been isolated from a soil by the present inventors, and Pseudomonas DS-K-NR 818 is a mutant thereof. These microorganisms have been classified in accordance with Bergey's Manual of Systematic Bacteriology, 8th and 9th Editions based on the morphological and physiological properties of them. As a result, they are Gram negative, aerobic rods and have polar flagella and are positive in the test with an oxidase and a catalase, and hence, they have been identified as a species of the genus Pseudomonas, and further since they are not identical to any known species, they have been designated as mentioned above and have been deposited with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan under Budapest Treaty with an accession number of FERM BP-994 and FERM BP-5491, respectively. The mycological properties of Pseudomonas sp. OS-K-29 are disclosed in JP-A-1-55879. The Pseudomonas OS-K-29 can be cultured in any conventional medium in which this microorganism can grow. The medium contains, for example, a carbon source such as hydrocarbons (e.g. glucose, galactose, sucrose), alcohols (e.g. glycerol, racemic 3-halogeno-1,2-propandiol, (R)- or (S)-3-halogeno-1,2-propandiol, racemic 2,3-dichloro-1-propanol, (R)-2,3-dichloro-1-propanol), organic acids (e.g. acetic acid, citric acid, malic acid, maleic acid, fumaric acid, gluconic acid) or salts thereof, or a mixture thereof; a nitrogen source such as inorganic nitrogen compounds (e.g. ammonium sulfate, ammonium nitrate, ammonium phosphate), organic nitrogen compounds (e.g. urea, peptone, casein, yeast extract, meat extract, corn steep liquor), or a mixture thereof; and may further contain an inorganic salt (e.g. a phosphate, a magnesium salt, a potassium salt, a manganese salt, an iron salt, a zinc salt, a copper salt) and further vitamins. In order to obtain cells of these microorganisms having high enzymatic activities, the medium as mentioned above and a nutrient medium such as a peptone medium, a bouillon medium for culturing of the microorganism may further include a racemic 3-halogeno-1,2-propanediol, (R)- or (S)-3-halogeno-1,2-propanediol, a racemic 2,3-dichloro-1-propanol, and (R)-2,3-dichloro-1-propanol. It may also be effective to use a completely synthetic medium containing as a single carbon source a racemic 2,3-dichloro-1-propanol, (R)-2,3-dichloro-1-propanol, or a racemic 3-halogeno-1,2-propanediol. The culture of the above microorganisms can be carried out in a usual manner, for example, at pH 6 - 9, preferably pH 6.5 - 7.5, a temperature of 20 to 40°C, preferably 25 to 37°C, under an aerobic condition, for 10 to 96 hours. The mycological properties of Pseudomonas sp. DS-K-NR 818 are as follows: A. Morphological properties Shape of cells rods Size of cells 0.4-0.6 x 1.2-1.6 µm Pleomorphisms of cells none Mobility +, polar flagella Spores none Gram stain negative Acid fastness none B. Growth in various media 1. Bouillon-agar medium (culture at 30°C for 3 days) 1) Speed of colony growth ordinary 2) Shape of colonies circular 3) Shape of colony surface smooth 4) Raised condition of colonies convex 5) Periphery of colonies entire 6) Contents of colonies homogeneous 7) Color of colonies milky white 8) Gloss of colonies dull 9) Transparency of colonies translucent 10) Formation of soluble pigment none 2. Bouillon-agar slant medium (culture at 30°C for 3 days) 1) Growth degree good 2) Growth condition filiform 3) Shape of colony surface smooth 4) Shape of colonies in section flat 5) Gloss of colonies dull 6) Color of colonies milky white 7) Transparency of colonies translucent 3. Bouillon liquid stationary culture (at 30°C for 3 days) 1) Growth condition somewhat turbid 2) Generation of gas none 3) Coloring of medium none 4) Liquification of gelatin no liquification 5) Litmus milk no agglutination, no change C. Physiological properties Decarboxylation of lysine positive VP test negative MR test negative Reduction of nitrate negative Production of indole negative PPA reaction negative Production of hydrogen sulfide negative Utilization of citric acid positive Hydrolysis of starch negative Denitrification negative Utilization of inorganic salts positive Production of pigment: 1) King's A medium negative 2) King's B medium negative 3) Pseudomonas P medium negative 4) Pseudomonas F medium negative Catalase positive Oxidase positive Urease test positive OF-test (by Hugh Leifson method, no gas generation): 1) D-Glucose negative 2) Glycerin oxidative 3) D-Galactose negative 4) D-Fructose negative 5) D-Trehalose negative Accumulation of PHB positive Utilization of carbon source: 1) D-Mannitol negative 2) D-Fructose positive 3) D-Glucose negative 4) D-Gluconic acid positive 5) D-Galactose negative 6) Glycerin positive 7) p-Hydroxybenzoic acid positive Optimum pH for growth 5 - 9 Optimum temperature for growth 20 - 40°C The Pseudomonas DS-K-NR 818 can be cultured in any conventional medium in which this microorganism can grow. The medium contains, for example, a carbon source such as hydrocarbons (e.g. fructose), alcohols (e.g. glycerol, racemic 3-halogeno-1,2-propandiol, racemic 2,3-dichloro-1-propanol), organic acids (e.g. acetic acid, citric acid, malic acid, maleic acid, fumaric acid, gluconic acid) or salts thereof, or a mixture thereof; a nitrogen source such as inorganic nitrogen compounds (e.g. ammonium sulfate, ammonium nitrate, ammonium phosphate), organic nitrogen compounds (e.g. urea, peptone, casein, yeast extract, meat extract, corn steep liquor), or a mixture thereof; and may further contain an inorganic salt (e.g. a phosphate, a magnesium salt, a potassium salt, a manganese salt, an iron salt, a zinc salt, a copper salt) and further vitamins. In order to obtain cells of these microorganisms having high enzymatic activities, the medium as mentioned above and a nutrient medium such as a peptone medium, a bouillon medium for culturing of the microorganism may further include a racemic 3-halogeno-1,2-propanediol, 2,3-dichloro-1-propanol. It may also be effective to use a completely synthetic medium containing as a single carbon source a racemic 3-halogeno-1,2-propanediol or 2,3-dichloro-1-propanol. The culture of the above microorganism can be carried out in a usual manner, for example, at a pH 6 - 9, preferably pH 6.5 -7.5, a temperature of 20 to 40°C, preferably 25 to 37°C, under an aerobic condition, for 10 to 96 hours. The other microorganisms used in the present invention, Enterobacter sp. DS-S-75, Citrobacter freundii DS-S-13, Citrobacter freundii DS-K-40, and Bacillus sphaericus DS-ID-819 have also been isolated from a soil by the present inventors. These microorganisms have been classified in accordance with Bergey's Manual of Systematic Bacteriology, 9th Edition based on the morphological and physiological properties of them. As a result, the Enterobacter sp. DS-S-75 is Gram negative, facultative anaerobic rods and has peripheral flagella and is positive in the V-P test, negative in the MR test and negative in DNase activity, and hence, it has been identified as a species of the genus Enterobacter , and further since it is not identical to any known species, it has been designated as mentioned above and has been deposited with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan under Budapest Treaty with an accession number of FERM BP-5494. Likewise, the Citrobacter freundii DS-S-13 and Citrobacter freundii DS-K-40 are Gram negative, facultative anaerobic rods and have peripheral flagella and are negative in the V-P test and can utilize citric acid as a single carbon source, and hence, they have been identified as a species of the genus Citrobacter . According to a further test, they produce hydrogen sulfide. In view of these properties, they are identified as a strain of Citrobacter freundii and have been designated as mentioned above and have been deposited with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan under Budapest Treaty with an accession number of FERM BP-5492 and FERM BP-5493, respectively. Likewise, the Bacillus sphaericus DS-ID-819 is Gram positive, aerobic rods, has peripheral flagella, forms spores, and is positive in the catalase test and hence, it has been identified as a species of the genus Bacillus. In view of the physiological properties in addition to those properties, it has been designated as a strain of Bacillus sphaericus and has been deposited with the National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Japan under Budapest Treaty with an accession number of FERM BP-5495. The mycological properties of Enterobacter sp. DS-S-75 are as follows: A. Morphological properties Shape of cells rods Size of cells 0.6-0.8 x 1.5-2.8 µm Pleomorphisms of cells none Mobility +, peripheral flagella Spores none Gram stain negative B. Growth in various media 1. Bouillon-agar medium (culture at 30°C for 3 days) 1) Size of colonies 3 - 4 mm 2) Shape of colonies irregular 3) Speed of colony growth rapidly 4) Shape of colony surface smooth, mucoid 5) Raised condition of colonies convex 6) Periphery of colonies undulate 7) Color of colonies milky white 8) Gloss of colonies dull 9) Transparency of colonies opaque 10) Formation of soluble pigment none 2. Bouillon-agar slant medium (culture at 30°C for 3 days) 1) Growth degree good 2) Growth condition filiform 3) Gloss of colonies dull 4) Color of colonies milky white 3. Bouillon liquid stationary culture (at 30°C for 3 days) 1) Growth condition turbid 2) Coloring of medium none 3) Sediment observed C. Physiological properties Production of indole negative Catalase positive Urease positive Oxidase negative β-Galactosidase positive Lysine decarboxylase positive Production of hydrogen sulfide negative Utilization of citric acid positive Hydrolysis of starch negative Liquification of gelatin negative MR test negative VP test positive Reduction of nitrate positive Denitrification positive DNase activity negative NPTase positive O-F test (glucose) fermentative D-Glucose, acid positive D-Glucose, gas positive Decomposition of saccharides (production of acid in +) D-Mannitol + Sucrose + Lactose - D-Sorbitol + Utilization of carbon source: D-Glucose positive D-Galactose positive Lactose positive Sucrose positive D-Mannitol positive Glycerin positive D-Gluconic acid positive p-Hydroxybenzoic acid positive D-Galactitol positive D-Sorbitol positive Optimum temperature for growth 30 - 37°C Optimum pH for growth 5 - 9 The mycological properties of Citrobacter freundii DS-S-13 are as follows: A. Morphological properties Shape of cells rods Size of cells 0.5-0.7 x 1.8-3.6 µm Pleomorphisms of cells none Mobility +, peripheral flagella Spores none Gram stain negative B. Growth in various media 1. Bouillon-agar medium (culture at 30°C for 3 days) 1) Size of colonies 2 - 4 mm 2) Shape of colonies circular 3) Speed of colony growth rapidly 4) Shape of colony surface smooth 5) Raised condition of colonies convex 6) Periphery of colonies entire 7) Color of colonies milky white 8) Gloss of colonies shiny surface 9) Transparency of colonies translucent 10) Formation of soluble pigment none 2. Bouillon-agar slant medium (culture at 30°C for 3 days) 1) Growth degree good 2) Growth condition echinulate 3) Gloss of colonies shiny surface 4) Color of colonies milky white 3. Bouillon liquid stationary culture (at 30°C for 3 days) 1) Growth condition turbid 2) Coloring of medium none 3) Sediment observed C. Physiological properties Production of indole negative Catalase positive Urease positive Oxidase negative β-Galactosidase positive Lysine decarboxylase negative Production of hydrogen sulfide positive Utilization of citric acid positive Hydrolysis of starch negative Liquification of gelatin negative MR test positive VP test negative Reduction of nitrate positive Denitrification positive DNase activity negative NPTase negative O-F test (glucose) fermentative D-Glucose, acid positive D-Glucose, gas positive Decomposition of saccharides (production of acid in +) D-Mannitol + Sucrose + Lactose + D-Sorbitol + Utilization of carbon source D-Glucose positive D-Galactose positive Lactose positive Sucrose positive D-Mannitol positive Glycerin positive D-Gluconic acid positive p-Hydroxybenzoic acid positive D-Galactitol negative D-Sorbitol positive Optimum temperature for growth 25 - 30°C Optimum pH for growth 5 - 9 The mycological properties of Citrobacter freundii DS-K-40 are as follows: A. Morphological properties Shape of cells rods Size of cells 0.5-0.7 x 1.8-3.6 µm Pleomorphisms of cells none Mobility +, peripheral flagella Spores none Gram stain negative B. Growth in various media 1. Bouillon-agar medium (culture at 30°C for 3 days) 1) Size of colonies 2 - 4 mm 2) Shape of colonies circular 3) Speed of colony growth rapidly 4) Shape of colony surface smooth 5) Raised condition of colonies convex 6) Periphery of colonies entire 7) Color of colonies milky white 8) Gloss of colonies shiny surface 9) Transparency of colonies translucent 10) Formation of soluble pigment none 2. Bouillon-agar slant medium (culture at 30°C for 3 days) 1) Growth degree good 2) Growth condition echinulate 3) Gloss of colonies shiny surface 4) Color of colonies milky white 3. Bouillon liquid stationary culture (at 30°C for 3 days) 1) Growth condition turbid 2) Coloring of medium none 3) Sediment observed C. Physiological properties Production of indole negative Catalase positive Urease positive Oxidase negative β-Galactosidase positive Lysine decarboxylase negative Production of hydrogen sulfide positive Utilization of citric acid positive Hydrolysis of starch negative Liquification of gelatin negative MR test positive VP test negative Reduction of nitrate positive Denitrification positive DNase activity negative NPTase negative O-F test (glucose) fermentative D-Glucose, acid positive D-Glucose, gas positive Decomposition of saccharides (production of acid in +) D-Mannitol + Sucrose + Lactose + D-Sorbitol + Utilization of carbon source: D-Glucose positive D-Galactose positive Lactose positive Sucrose positive D-Mannitol positive Glycerin positive D-Gluconic acid positive p-Hydroxybenzoic acid positive D-Galactitol: negative D-Sorbitol: positive Optimum temperature for growth: 25 - 30°C Optimum pH for growth: 5 - 9 The mycological properties of Bacillus sphaericus DS-ID-819 are as follows: A. Morphological properties Shape of cells rods Size of cells 0.5-0.7 x 2.0-3.5 µm Pleomorphisms of cells none Mobility +, peripheral flagella Spores endospore Gram stain positive B. Growth in various media 1. Bouillon-agar medium (culture at 30°C for 3 days) 1) Size of colonies 2 - 4 mm 2) Shape of colonies circular 3) Speed of colony growth ordinary 4) Shape of colony surface wrinkled 5) Raised condition of colonies flat 6) Periphery of colonies entire 7) Color of colonies milky white 8) Gloss of colonies dull 9) Transparency of colonies translucent 10) Formation of soluble pigment none 2. Bouillon-agar slant medium (culture at 30°C for 3 days) 1) Growth degree good 2) Growth condition spreading 3) Gloss of colonies dull 4) Color of colonies milky white 3. Bouillon liquid stationary culture (at 30°C for 3 days) 1) Growth condition somewhat turbid 2) Coloring of medium none 3) Sediment none C. Physiological properties Production of indole negative Catalase positive Urease positive Oxidase positive β-Galactosidase negative Lysine decarboxylase positive Production of hydrogen sulfide negative Utilization of citric acid positive Hydrolysis of starch negative Liquification of gelatin positive MR test negative VP test negative Reduction of nitrate negative Denitrification negative DNase activity positive NPTase negative O-F test (glucose) oxidative D-Glucose, acid negative D-Glucose, gas negative Decomposition of saccharides (production of acid in +) D-Mannitol - Sucrose - Lactose - D-Sorbitol - Utilization of carbon source: D-Glucose negative D-Galactose negative Lactose negative Sucrose negative D-Mannitol negative Glycerin positive D-Gluconic acid negative Sodium acetate positive Glycine positive D-Galactitol negative D-Sorbitol negative Optimum temperature for growth 30 - 37°C Optimum pH for growth 6 - 9 The above microorganisms, Enterobacter sp. DS-S-75, Citrobacter freundii DS-S-13, Citrobacter freundii DS-K-40, and Bacillus sphaericus DS-ID-819 can be cultured in any conventional medium in which these microorganisms can grow. The medium contains, for example, a carbon source such as hydrocarbons (e.g. glucose, galactose, fructose), alcohols (e.g. glycerol), organic acids (e.g. acetic acid, citric acid, malic acid, maleic acid, fumaric acid, gluconic acid) or salts thereof, or a mixture thereof; a nitrogen source such as inorganic nitrogen compounds (e.g. ammonium sulfate, ammonium nitrate, ammonium phosphate), organic nitrogen compounds (e.g. urea, peptone, casein, yeast extract, meat extract, corn steep liquor), or a mixture thereof; and may further contain an inorganic salt (e.g. a phosphate, a magnesium salt, a potassium salt, a manganese salt, an iron salt, a zinc salt, a copper salt) and further vitamins. The culture of the above microorganisms can be carried out in a usual manner, for example, at pH 5 - 9, preferably pH 6.5 - 7.0, a temperature of 20 to 40°C, preferably 25 to 37°C, under an aerobic condition, for 10 to 96 hours. The production of an optically active chlorohydrin and an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone by the treatment of a racemic chlorohydrin compound with a microorganism may be carried out by using the microorganism in the form of 1) a culture broth obtained by culturing the microorganism in the method as described above, 2) cells of the microorganism obtained by centrifuging the culture broth or a processed product of the cells (e.g. fractured cells or cell extracts), or 3) an immobilized product of these cells or processed products thereof. The biological optical resolution of this invention is carried out by using these microbial cell products. The microbial cell product is mixed in a buffer, and the substrate (i.e. racemic chlorohydrin compound) is added to said mixture of microbial cell product in a buffer and then is subjected to the degradation reaction. The reaction is preferably carried out at a temperature of 15 to 50°C and at a pH 6 to 9. The substrate is preferably contained in a concentration of 0.1 to 15 %(v/v). The substrate may be added in one portion at the beginning of the reaction or may be added in several portions. The reaction is usually carried out with stirring or shaking, and the reaction period of time may vary depending on the concentration of the substrate and the amount of microbial cell product, but is usually in the range of 1 to 120 hours. Preferably, the endpoint of the reaction is determined by analysis with gas chromatography etc., that is, when the resulting optically active product reaches the maximal optical purity. The optically active chlorohydrin and an optically active 1,2-diol compound and/or an optically active 3-hydroxy-γ-butyrolactone contained in the reaction mixture are collected and purified by a conventional method. For instance, after removing the microbial cell product by centrifuging, the supernatant is concentrated with an evaporator, and extracted with a solvent (e.g. ethyl acetate). The extract is dried over anhydrous magnesium sulfate and the solvent is evaporated under reduced pressure to give a syrup of the optically active chlorohydrin compound. When an optically active 1,2-diol compound is produced, the syrup contains also the 1,2-diol compound together with the optically active chlorohydrin compound, and hence, these compounds are separated and purified by distillation or column chromatography. Besides, when an optically active 3-hydroxy-γ-butyrolactone is produced, it is also isolated in the following manner. That is, the reaction mixture is centrifuged to remove the microbial cell product, and the supernatant is extracted with a solvent (e.g. ethyl acetate), and the optically active chlorohydrin and 1,2-diol compounds are separated, and the remaining aqueous layer is concentrated to give a crude syrup of the optically active 3-hydroxy-γ-butyrolactone. Alternatively, the aqueous layer may be treated with an active carbon and then the desired compound is separated and purified in a usual manner. The products may further be purified by a conventional purification method such as treatment with an active carbon, or a silica gel column chromatography. The present invention is illustrated in more detail by the following Examples but should not be constructed to be limited thereto. Unless otherwise indication, percentages in the examples are expressed by w/v percentage. Example 1 2.5 L of a nutrient medium (pH 7.2) containing each 1% of peptone, yeast extract and glycerol were added into a 5 L volume jar fermenter and sterilized at 121°C for 15 minutes under high pressure. Pseudomonas sp. OS-K-29 strain was previously subjected to a shake culture at 30°C for 16 hours in a nutrient medium (pH 7.2) containing each 1.0% of peptone, yeast extract and glycerol to give a seed culture, and the seed culture thus obtained was inoculated on the above medium in an amount of 2% (v/v) under sterile condition. Then, the inoculated medium was subjected to an agitation culture under aeration of 1.0 Umin at 30°C for about 24 hours at 500 rpm. After completion of the cultivation, the culture solution was centrifuged to collect the cells and the cells were washed with 20 mM phosphate buffer solution (pH 7.2, containing 2 mM magnesium sulphate) three times to give resting cells. The cells were suspended in 100 ml of the same buffer solution containing 1.0% calcium carbonate in a 500 ml volume Erlenmeyer flask with baffle and added thereto 1.0% (v/v) of racemic 4-chloro-3-hydroxybutyronitrile and then they were reacted at 30°C for 90 hours with stirring. The reaction mixture was subjected to a gas chromatography (column support material: PEG 20M, 60-80 mesh) for the determination of remaining 4-chloro-3-hydroxybutyronitrile. The percentage of remaining 4-chloro-3-hydroxybutyronitrile was 40.1%. After completion of the reaction, the reaction mixture was centrifuged to remove the cells, concentrated to about 1 ml and extracted with ethyl acetate. After dehydration with anhydrous magnesium sulphate, the solvent was removed in vacuo to give 380 mg of 4-chloro-3-hydroxybutyronitrile and 350 mg of 1,2-diol compound which corresponded to the substrate. The identification and determination of this material were carried out by the gas chromatography as described above and confirmed by its retention time. This syrup was subjected to a gas chromatography using a capillary column G-TA (0.25 mm x 30 m, manufactured by Advanced Separation Technologies Inc., NJ, USA) to analyse optical isomers of 4-chloro-3-hydroxybutyronitrile therein. Separately, the 1,2-diol compound was analyzed by the above gas chromatography as to the optical isomers likewise, after being trifluorated with anhydrous trifluoroacetic acid. It was shown by the results that the recovered 4-chloro-3-hydroxybutyronitrile was the S-isomer with an optical purity of 94.5%ee. It was also shown that the recovered 1,2-diol compound was the R-isomer with an optical purity of 42.2%ee. The above gas chromatography analysis for optical isomers was carried out under the following conditions. The retention time of 4-chloro-3-hydroxybutyronitrile was 64.1 min (S-isomer) arid 66.5 min (R-isomer). The retention time of 1,2-diol compound was 113.1 min (S-isomer) and 125.3 min (R-isomer). Conditions for analysis: Column temperature: 120°C; detector temperature: 200°C; carrier gas: nitrogen; flow rate: 0.5 ml/min; detector: FID; split ratio: 100/1. Examples 2 to 7 The reaction was carried out by the same procedure as in Example 1 except that substrates shown in Table 1 were substituted for racemic 4-chloro-3-hydroxybutyronitrile. The identification and determination as well as analysis for optical isomers of the various compounds thus obtained were carried out by the same procedure as in Example 1. In Examples 3 to 5, 3-hydroxy-γ-butyrolactone was obtained as a crude syrup by removing the cells from the reaction mixture, treating the supernatant with the same amount of ethyl acetate to extract the chlorohydrin and 1,2-diol compound and concentrating the aqueous layer. This material was identified and determined by the gas chromatography as described in Example 1 and confirmed by its retention time. The optical purity of 3-hydroxy-γ-butyrolactone in this syrup was determined by the gas chromatography using a capillary column G-TA (0.25 mm x 30 m, manufactured by Advanced Separation Technologies Inc., NJ, USA) as described in Example 1, after being acetylated with acetyl chloride. The retention time of 3-hydroxy-γ-butyrolactone was 11.3 min (S-isomer) and 12.0 min (R-isomer). Conditions for analysis: Column temperature: 150°C; detector temperature: 200°C; carrier gas: nitrogen; flow rate: 0.7 ml/min; detector: FID; split ratio: 100/1. The physical properties of the obtained 3-hydroxy-γ-butyrolactone were well identical to the data described in "Synthetic Communications", 16(2), pp.183-190,1986. 1 H-NMR (CDCl 3 , 250 MHz), δppm: 2.54 (d, 1H, J=18Hz); 2.79 (dd, 1H, J=18Hz, J=6Hz); 3.29 (s, 1H, OH); 4.34 (d, 1H, J=10Hz); 4.46 (dd, 1H, J=10Hz, J=4.5Hz); 4.6-4.7 (m, 1H); 13 C-NMR (CDCl 3 ), δppm: 177, 76.3, 67.2, 37.7. The products and their yield in Examples 1 to 7 are shown in Table 1. Example 8 2.5 L of a nutrient medium (pH 7.0) containing each 1% of peptone, yeast extract and glycerol were added into of a 5 L volume jar fermenter and sterilized at 121°C for 15 minutes under high pressure. Pseudomonas sp. DS-K-NR818 strain was previously subjected to a shake culture at 30°C for 18 hours in a nutrient medium (pH 7.0) containing each 1.0% of peptone, yeast extract and glycerol to give a seed culture, and the seed culture was inoculated on the above medium in an amount of 2.0% (v/v) under sterile condition. Then, the inoculated medium was subjected to an agitation culture under aeration of 0.5 L/min at 30°C for about 24 hours with rotary mixing at 500 rpm. After completion of the cultivation, the culture solution was centrifuged to collect cells and the cells were washed with 20 mM phosphate buffer solution (pH 7.2, containing 2 mM magnesium sulphate) three times to give resting cells. The cells were suspended in 100 ml of the same buffer solution in a 500 ml volume Erlenmeyer flask with baffle and added thereto 1.0% (v/v) of racemic ethyl 4-chloro-3-hydroxybutyrate and they were reacted at 30°C for 40 hours. The reaction mixure was subjected to a gas chromatography (column support material: PEG 20M, 60-80 mesh) for the determination of remaining ethyl 4-chloro-3-hydroxybutyrate. The percentage of remaining ethyl 4-chloro-3-hydroxybutyrate was 41.8%. After completion of the reaction, the reaction mixture was centrifuged to remove the cells, concentrated to about 1 ml and extracted with ethyl acetate. After dehydration with anhydrous magnesium sulphate, the solvent was removed in vacuo to give 406 mg of ethyl 4-chloro-3-hydroxybutyrate. This material was identified and determined by the gas chromatography as described above and confirmed by its retention time. The optical isomer of the remaining ethyl 4-chloro-3-hydroxybutyrate was analyzed by a gas chromatography using a capillary column G-TA (0.25 mm x 30 m, manufactured by Advanced Separation Technologies Inc., NJ, USA). It was shown by the results that the recovered ethyl 4-chloro-3-hydroxybutyrate was the R-isomer with an optical purity of >98%ee. The above gas chromatography analysis for optical isomers was carried out under the following conditions. The retention time of ethyl 4-chloro-3-hydroxybutyrate was 39.5 min (R-isomer) and 41.0 min (S-isomer). Conditions for analysis: Column temperature: 110°C; detector temperature: 200°C; carrier gas: nitrogen; flow rate: 0.7 ml/min; detector: FID; split ratio: 100/1. 3-Hydroxy-γ-butyrolactone was obtained as a crude syrup by removing the cells from the reaction mixture, treating the supernatant with a same amount of ethyl acetate to extract chlorohydrin and then concentrating the aqueous layer. The identification and determination as well as the analysis for optical isomers of the compound were carried out by the same procedure as in Example 3. Examples 9 to 12 The reaction was carried out by the same procedure as in Example 8 except that the substrates shown in Table 2 were substituted for the racemic ethyl 4-chloro-3-hydroxybutyrate. The identification and determination as well as the analysis for optical isomers of the various compounds thus obtained were also carried out by the same procedure as in Example 8. The products and their yield in Examples 8 to 12 are shown in Table 2. Example 13 Preparation of (S)-3-hydroxy-γ-butyrolactone and (R)-methyl 4-chloro-3-hydroxybutyrate 100 ml of a nutrient medium (pH 7.0) containing each 1% of peptone, yeast extract and glycerol were added into a 500 ml volume Erlenmeyer flask and sterilized at 121°C for 15 minutes under high pressure. Enterobacter sp. DS-S-75 strain was previously subjected to a shake culture at 30°C for 20 hours in a nutrient medium (pH 7.0) containing each 1.0% of peptone, yeast extract and glycerol to give a seed culture, and the seed culture was inoculated on the above medium in an amount of 2.0% (v/v) under sterile condition. Then, the inoculated medium was subjected to an agitation culture at 30°C for about 24 hours. After completion of the cultivation, the culture solution was centrifuged to collect cells and the cells were washed with 20 mM phosphate buffer solution (pH 7.2, containing 2 mM magnesium sulphate) three times to give resting cells. The cells were suspended in 100 ml of the same buffer solution in a 500 ml Erlenmeyer flask with baffle and added thereto 1.0% (v/v) of racemic methyl 4-chloro-3-hydroxybutyrate, and they were reacted at 30°C for 24 hours. The reaction mixture was subjected to a gas chromatography (column support material: PEG 20M, 60-80 mesh) for the determination of remaining methyl 4-chloro-3-hydroxybutyrate. The percentage of remaining methyl 4-chloro-3-hydroxybutyrate was 48.0%. After completion of the reaction, the reaction mixture was centrifuged to remove the cells and the supernatant was flowed through a column packed with active carbon and eluted with acetone. Acetone was evaporated in vacuo from the eluate, and the residual oily substance was distilled to give 342 mg of (R)-methyl 4-chloro-3-hydroxybutyrate (b.p. 75-80/1.5 mmHg) and 214 mg of (S)-3-hydroxy-γ-butyrolactone (b.p. 110-120/0.5 mmHg) as an oil. The obtained methyl 4-chloro-3-hydroxybutyrate was the R-isomer with an optical purity of >99%ee. The obtained 3-hydroxy-γ-butyrolactone was acetylated with acetyl chloride and then its optical purity was determined. Said 3-hydroxy-γ-butyrolactone was the S-isomer with an optical purity of 95.9%ee. A gas chromatography using a capillary column G-TA (0.25 mm x 30 m, manufactured by Advanced Separation Technologies Inc., NJ, USA) was used for the above determination of the optical purity. The gas chromatography analysis for optical isomers was carried out under the following conditions. Conditions for analysis of methyl 4-chloro-3-hydroxybutyrate: Column temperature: 110°C; detector temperature: 200°C; carrier gas: nitrogen; flow rate: 0.7 ml/min; detector: FID; split ratio: 100/1. Retention time: 15.5 min (R-isomer); 16.3 min (S-isomer). Conditions for analysis of 3-hydroxy-γ-butyrolactone: Column temperature: 150°C; detector temperature: 200°C; carrier gas: nitrogen; flow rate: 0.7 ml/min; detector: FID; split ratio: 100/1. Retention time: 11.3 min (S-isomer); 12.0 min (R-isomer). The physical properties of the obtained 3-hydroxy-γ-butyrolactone were well identical to the data described in "Synthetic Communications", 16(2), pp.183-190,1986. [α] D 20 =-76.2° (c=1.95, EtOH); 1 H-NMR (CDCl 3 , 250 MHz), δppm: 2.54 (d, 1H, J=18Hz); 2.79 (dd, 1H, J=18Hz, J=6Hz); 3.29 (s, 1H, OH); 4.34 (d, 1H, J=10Hz); 4.46 (dd, 1H, J=10Hz, J=4.5Hz); 4.6-4.7 (m, 1H); 13 C-NMR (CDCl 3 ), δppm: 177, 76.3, 67.2, 37.7. Examples 14 to 32 A reaction was carried out by the same procedure as in Example 13 except that the substrates shown in Table 3 were substituted for the racemic methyl 4-chloro-3-hydroxybutyrate and Enterobacter sp. DS-S-75, Citrobacter freundii DS-S-13, Citrobacter freundii DS-K-40 and Bacillus sphaericus DS-ID-819 were used as the microorganism for each substrate. The determination as well as the analysis for optical isomers of the various compounds thus obtained were also carried out by the same procedure as in Example 13. The yield and optical purity of the obtained compounds are shown in Table 3. The physical properties of the 3-hydroxy-γ-butyrolactone obtained in all these examples were identrical to the data of Example 13. The products and their yield in Examples 13 to 32 are shown in Table 3. The meaning of the abbreviations in this table are as follows. MH: Methyl 4-chloro-3-hydroxybutyrate EH: Ethyl 4-chloro-3-hydroxybutyrate IPH: Isopropyl 4-chloro-3-hydroxybutyrate PH: Propyl 4-chloro-3-hydroxybutyrate BH: Butyl 4-chloro-3-hydroxybutyrate HL: 3-Hydroxy-γ-butyrolactone No. 75: Enterobacter sp. DS-S-75 No. 13: Citrobacter freundii DS-S-13 No. 40: Citrobacter freundii DS-K-40 No. 819: Bacillus sphaericus DS-ID-819 Ex. Strain Substrate Product (optical purity and yield) 13 No.75 MH R-MH >99%ee, 342 mg S-HL 95.9%ee, 214 mg 14 No.75 EH R-EH >99%ee, 304 mg S-HL 92.4%ee, 214 mg 15 No.75 IPH R-IPH >99%ee, 362 mg S-HL 96.8%ee, 170 mg 16 No.75 PH R-PH 96.6%ee, 374 mg S-HL 96.6%ee, 164 mg 17 No.75 BH R-BH >99%ee, 462 mg S-HL 96.7%ee, 129 mg 18 No.13 MH R-MH 72.5%ee, 419 mg S-HL 93.7%ee, 169 mg 19 No.13 EH R-EH >99%ee, 332 mg S-HL 95.4%ee, 172 mg 20 No.13 IPH R-IPH >99%ee, 382 mg S-HL 94.4%ee, 160 mg 21 No.13 PH R-PH >99%ee, 405 mg S-HL 98.3%ee, 149 mg 22 No.13 BH R-BH >99%ee, 409 mg S-HL 96.5%ee, 136 mg 23 No.40 MH R-MH 59.3%ee,432 mg S-HL 95.5%ee, 162 mg 24 No.40 EH R-EH 98.3%ee, 354 mg S-HL 95.3%ee, 187 mg 25 No.40 IPH R-IPH >99%ee, 344 mg S-HL 96.3%ee, 178 mg 26 No.40 PH R-PH >99%ee, 431 mg S-HL 98.4%ee, 136 mg 27 No.40 BH R-BH >99%ee, 401 mg S-HL 96.8%ee, 140 mg 28 No.819 MH S-MH 91.9%ee, 306 mg R-HL 42.0%ee, 136 mg 29 No.819 EH S-EH >99%ee, 267 mg R-HL 23.5%ee, 141 mg 30 No.819 IPH S-IPH 94.5%ee, 320 mg R-HL 65.5%ee, 83 mg 31 No.819 PH S-PH 28.5%ee, 175 mg R-HL 7.9%ee, 202 mg 32 No.819 BH R-BH 31.1%ee, 222 mg S-HL 4.8%ee, 179 mg According to the present invention, the optically active chlorohydrin and optically active 1,2-diol compound and/or optically active 3-hydroxy-γ-butyrolactone can be produced by using inexpensive materials with ease and on industrial scale, which comprises degrading one of the optical isomers of a racemic chlorohydrin compound of the formula [1] with a microorganism of the genus Pseudomonas (e.g. Pseudomonas sp. OS-K-29 or Pseudomonas sp. DS-K-NR818), the genus Enterobacter (e.g. Enterobacter sp. DS-S-75), the genus Citrobacter (e.g. Citrobacter freundii DS-S-13, Citrobacter freundii DS-K-40) as well as the genus Bacillus (e.g. Bacillus sphaericus DS-ID-819) whereby the other optical isomer remains in the reaction system, and further dehalogenating only one of the optical isomers to convert it into an optically active 1,2-diol compound or 3-hydroxy-γ-butyrolactone, and then recovering the remaining optically active chlorohydrin compound and the produced optically active 1,2-diol compound and/or optically active 3-hydroxy-γ-butyrolactone. The optically active chlorohydrin compound and the optically active 1,2-diol compound and/or optically active 3-hydroxy-γ-butyrolactone which are obtained by the present invention are useful as intermediates for preparing medicaments, agricultural chemicals, physiologically active substances and ferroelectric liquid crystals. Especially, the optically active 4-chloro-3-hydroxybutyronitrile and the corresponding carboxylate (i.e. the optically active methyl 4-chloro-3-hydroxybutyrate and ethyl 4-chloro-3-hydroxybutyrate, etc.) which have a C4-structure are important as a precursor compound for preparing pharmaceutically useful compounds such as optically active carnitine, 4-chloro-3-hydroxybutanoic acid, 4-hydroxy -2-pyrrolidone and 1,2,4-butanetriol. Thus, the present invention can provide such important compounds inexpensively and conveniently and is very valuable from the industrial viewpoint.

Claims: A process for the optical resolution of a racemic chlorohydrin compound, which comprises treating a racemic mixture of a chlorohydrin compound of the formula: wherein R 1 is a hydrogen atom or a C 1 -C 4 alkyl group; and R 2 is a substituted or unsubstituted C 1 -C 3 alkyl group when R 1 is a hydrogen atom, provided that a hydroxymethyl group is excluded, or R 2 is a hydrogen atom when R 1 is a C 1 -C 4 alkyl group, with a culture broth or cells of a microorganism belonging to a bacteria of the genus Pseudomonas, Enterobacter, Citrobacter or Bacillus or a processed product thereof, and thereby degrading selectively only one of the optical isomers in the racemic mixture whereby the other optically active isomer remains in the reaction system. A process as claimed in claim 1, wherein the optically active chlorohydrin compound remaining in the reaction mixture is recovered. A process as claimed in claim 1 or 2, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is a substituted or unsubstituted C 1 -C 3 alkyl group. A process as claimed in any one of claims 1 to 3, wherein R 2 is selected from an ethyl group, a cyanomethyl group, an alkoxycarbonylmethyl group, in which the alkyl moiety has 1 to 4 carbon atoms, and an alkoxymethyl group in which the alkyl moiety has 1 to 4 carbon atoms. A process as claimed in claim 4 wherein R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms. A process as claimed in claim 5 wherein R 2 is selected from methoxycarbonylmethyl, ethoxycarbonylmethyl, and isopropoxycarbonylmethyl. A process as claimed in claim 2, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a C 1 -C 4 alkyl group and R 2 is a hydrogen atom. A process as claimed in any one of claims 1 to 7, wherein the microorganism is a bacteria of the genus Pseudomonas. A process as claimed in any one of claims 3 to 6, wherein the microorganism is Pseudomonas sp. OS-K-29 (FERM BP 994). A process as claimed in claim 5 or 6, wherein the microorganism is a bacteria of the genus Enterobacter , Citrobacter or Bacillus. A process as claimed in claim 9, wherein an optically active 1,2-diol compound of the formula: wherein R 3 is a substituted or unsubstituted C 1 -C 3 alkyl group is produced in addition to the optically active chlorohydrin compound. A process as claimed in claim 2, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and the microorganism is Pseudomonas sp. OS-K-29 (FERM BP 994), and thereby an optically active 1,2-diol compound of the formula: wherein R 3' is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and further an optically active 3-hydroxy-γ-butyrolactone of the formula: are produced in addition to the optically active chlorohydrin compound. A process as claimed in claim 12, wherein R 3' is selected from methoxycarbonylmethyl, ethoxycarbonylmethyl, and isopropoxycarbonylmethyl. A process as claimed in any one of claims 5 to 7, wherein the microorganism is Pseudomonas sp. DS-K-NR 818 (FERM BP 5491). A process as claimed in claim 2, wherein the starting racemic chlorohydrin compound is a compound of the formula [1] wherein R 1 is a hydrogen atom and R 2 is an alkoxycarbonylmethyl group in which the alkyl moiety has 1 to 4 carbon atoms, and the microorganism is selected from Pseudomonas sp. DS-K-NR 818 (FERM BP 5491), Enterobacter sp. DS-S-75 (FERM BP 5494), Citrobacter freundii DS-S-13 (FERM BP 5492), Citrobacter freundii DS-K-40 (FERM BP 5493) , and Bacillus sphaericus DS-ID-819 (FERM BP 5495), and thereby an optically active 3-hydroxy-γ-butyrolactone of the formula: is produced in addition to the optically active chlorohydrin compound. A process as claimed in claim 15, wherein R 2 in the starting compound [1] is selected from methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, isopropoxycarbonylmethyl, and butyloxycarbonylmethyl.

Inventors: IDOGAKI HIDEAKI, KASAI NAOYA, SUZUKI TOSHIO, IDOGAKI, HIDEAKI, KASAI, NAOYA, SUZUKI, TOSHIO
Applicants: DAISO CO LTD, DAISO CO., LTD.
Application year: 1996
Main classification: C12P41
IPC codes: C12P17, C12P7, C12P41